Delivery Order SPE2DB24D1107-SPE2DB25FZGF1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams) with a ceiling value of $1,243.56. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,286.79 to supply Advair HFA 230-21 microgram inhalers (12 grams) with an ultimate completion date of November 14, 2025. This contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,552.67 delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhaler (12 grams) on September 10, 2025, with completion expected by September 11, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's existing pharmaceutical supply agreements with the federal government. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.09 to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12-gram units). This is a firm fixed-price, non-set-aside contract with a completion date of June 27, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,335.16 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a small-value transaction under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.35 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGF1Delivery Order
The Defense Logistics Agency awarded a $2,618.19 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhaler (12 grams) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurement requirements for the Defense Logistics Agency's Medical Supply Chain, supporting military healthcare systems and other government entities including the Defense Health Agency and U.S. Coast Guard. This Advair HFA delivery order represents a routine pharmaceutical supply transaction within the company's established prime vendor relationship with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/12/25 |